Oncology Pharmacy Residency PGY-2

The Children's National Postgraduate Year Two (PGY2) Oncology Pharmacy Residency Program provides learning experiences centered on patient care and practice management that will enable residency graduates to pursue advanced clinical pharmacist and clinical specialist positions in oncology after completion of the program. The residency program will also provide teaching opportunities that will develop pedagogical skills in the context of adjunct faculty appointments with affiliated pharmacy schools. An optional teaching certificate program will be available through the University of Maryland (this will be required for residents who have not previously completed one). The Division of Pharmacy is affiliated with Howard University School of Pharmacy, University of Maryland School of Pharmacy, Virginia Commonwealth University and Shenandoah University as well as other pharmacy schools around the country. 

Children’s National Hospital in Washington, D.C., consists of a 303-bed academic pediatric hospital, six regional outpatient centers, two suburban ambulatory care surgical locations, two community-based health centers, a home care service and a network of community-based physicians. Children's staff members are nationally and internationally known and provide care annually to more than 70,000 children and adolescents from 30 states, the District of Columbia and other countries. Children’s National Hospital has a comprehensive cancer program home to some of the world’s leading cancer and blood disorders experts.

Over 100 pharmacists have completed a residency at Children’s National since the start of the program in 1980. Children’s National is a participating member of the ASHP Residency Matching Program. The PGY2 Oncology Pharmacy Residency has been accredited since 2020 with one position available.